SERUM AMYLASE AS A BIOCHEMICAL MARKER TO PREDICT THE CLINICAL OUTCOME IN ORGANOPHOSPHORUS POISONING
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 49
Abstract
BACKGROUND Organophosphorus poisoning is one of the leading causes for suicidal deaths among the rural population of India. Serum cholinesterase is being used as a marker to assess the severity of OPC poisoning. Nowadays, serum amylase is being proposed for the same purpose due to its ready availability. The present study was carried out to estimate the serum amylase levels in organophosphorus poisoning patients and to correlate it with the clinical outcome of the patient. MATERIALS AND METHODS This cross-sectional study was conducted in the Emergency ward of Kanyakumari Government Medical College, Asaripallam during the period from September 2017 to October 2018. A total of 80 patients were included in the study after fulfilling the inclusion and exclusion criteria. Serum amylase levels were estimated at the time of admission and 48 hours after treatment. RESULTS In organophosphorus poisoning patients, serum amylase level was found to be significantly elevated at the time of admission (262.6 U/L). The mean amylase value was 374.5 U/L for the dead patients and 150.7 U/L for the live patients. These values were statistically significant with p<0.01. The severity of increase in serum amylase was directly proportional to the risk of developing respiratory failure and prolonged stay in the hospital. CONCLUSION Serum amylase can be used as a biochemical marker for organophosphorus intoxication and to predict the clinical outcome of the patients, since it enables early recognition of the risk of developing respiratory failure.
Authors and Affiliations
John Vinoj, Gogul Gogul, Shanmughasundaram Shanmughasundaram, Pooja Pooja
Keywords
Related Articles
- EP ID EP607605
- DOI 10.18410/jebmh/2018/683
- Views 94
- Downloads 0
AN OBSERVATIONAL PROSPECTIVE STUDY OF ADVERSE DRUG REACTIONS IN NEW SMEAR POSITIVE PATIENTS OF PULMONARY TUBERCULOSIS TREATED UNDER DIRECTLY OBSERVED TREATMENT IN CONTINUATION PHASE IN GENERAL MEDICINE OPD AT GULBARGA INSTITUTE OF MEDICAL SCIENCES, KALABURAGI
BACKGROUND The objective of this study was to study the adverse drug reaction profile of New Sputum-Smear Positive (NSP) patients of pulmonary tuberculosis (PTB) treated under DOTS in category-I, in continuation phase. A...
A STUDY OF MUCOCUTANEOUS MANIFESTATIONS IN AUTOIMMUNE CONNECTIVE TISSUE DISORDERS AT TERTIARY CARE CENTRE
BACKGROUND Our aim was to study the clinical and immunological profile of patients with newly detected connective tissue disease presented to a tertiary care centre. MATERIALS AND METHODS The study involved 51 patients w...
PREDICTORS OF RISK FOR ABNORMAL KARYOTYPE IN DYSMORPHIC CHILDREN
BACKGROUND Chromosomal anomalies occur in 0.4% of live births. The phenotypic anomalies that result from chromosomal aberrations have multiple minor face- and limb-anomalies. These assume diagnostic significance in combi...
DEXAMETHASONE-CYCLOPHOSPHAMIDE PULSE THERAPY IN PEMPHIGUS- A CLINICAL STUDY
BACKGROUND Pemphigus is an autoimmune bullous disorder which was life threatening before the advent of steroids and immunosuppressants. Dexamethasone Cyclophosphamide Pulse Therapy introduced by Pasricha and Gupta in 198...
COMPARISON OF AUTOBLOOD GRAFT FIXATION VS. CONJUNCTIVAL GRAFT FIXATION WITH POLYGLACTIN SUTURE IN PRIMARY PTERYGIUM SURGERY
BACKGROUND Pterygium is excessive sub-conjunctival proliferation of fibrovascular tissue or elastotic degeneration of tissue under the epithelium. Pterygium is seen nearly twice as often in men as in women. Ophthalmologi...